
### [NCIT:C43527](http://purl.obolibrary.org/obo/NCIT_C43527)
**Label:** Sporadic Gastric Adenocarcinoma

**Subclasses:** [NCIT:C27131](http://purl.obolibrary.org/obo/NCIT_C27131) (Early Gastric Cancer), [NCIT:C5248](http://purl.obolibrary.org/obo/NCIT_C5248) (Mucinous Gastric Adenocarcinoma), [NCIT:C5473](http://purl.obolibrary.org/obo/NCIT_C5473) (Gastric Tubular Adenocarcinoma), [NCIT:C95763](http://purl.obolibrary.org/obo/NCIT_C95763) (Gastric Intramucosal Adenocarcinoma), [NCIT:C27765](http://purl.obolibrary.org/obo/NCIT_C27765) (Helicobacter Pylori-Related Gastric Adenocarcinoma), [NCIT:C5250](http://purl.obolibrary.org/obo/NCIT_C5250) (Signet Ring Cell Gastric Adenocarcinoma), [NCIT:C9157](http://purl.obolibrary.org/obo/NCIT_C9157) (Gastric Intestinal-Type Adenocarcinoma), [NCIT:C5472](http://purl.obolibrary.org/obo/NCIT_C5472) (Gastric Papillary Adenocarcinoma), [NCIT:C95748](http://purl.obolibrary.org/obo/NCIT_C95748) (Gastric Carcinoma with Lymphoid Stroma), [NCIT:C67526](http://purl.obolibrary.org/obo/NCIT_C67526) (Gastric Mixed Adenocarcinoma), [NCIT:C95747](http://purl.obolibrary.org/obo/NCIT_C95747) (Gastric Hepatoid Adenocarcinoma), [NCIT:C43529](http://purl.obolibrary.org/obo/NCIT_C43529) (Sporadic Diffuse Gastric Adenocarcinoma), [NCIT:C95743](http://purl.obolibrary.org/obo/NCIT_C95743) (Poorly Cohesive Gastric Carcinoma), 

**Class expressions from DL-Learner:**

- [NCIT:C36318](http://purl.obolibrary.org/obo/NCIT_C36318) (Microsatellite Instability) and (not ([NCIT:C36493](http://purl.obolibrary.org/obo/NCIT_C36493) (High-Frequency Microsatellite Instability))) 56.25%
- Thing 52.88%
- [NCIT:C36391](http://purl.obolibrary.org/obo/NCIT_C36391) (Molecular Genetic Variation) 46.41%
- [NCIT:C97926](http://purl.obolibrary.org/obo/NCIT_C97926) (Molecular Sequence Variation) 46.16%
- [NCIT:C3910](http://purl.obolibrary.org/obo/NCIT_C3910) (Molecular Abnormality) 42.92%
- [NCIT:C48189](http://purl.obolibrary.org/obo/NCIT_C48189) (Genomic Instability) 41.61%
- [NCIT:C36318](http://purl.obolibrary.org/obo/NCIT_C36318) (Microsatellite Instability) 41.61%
- [NCIT:C36318](http://purl.obolibrary.org/obo/NCIT_C36318) (Microsatellite Instability) and (not ([NCIT:C39006](http://purl.obolibrary.org/obo/NCIT_C39006) (Bioactive Peptide Signaling Pathway))) 41.61%
- [NCIT:C36318](http://purl.obolibrary.org/obo/NCIT_C36318) (Microsatellite Instability) and (not ([NCIT:C39004](http://purl.obolibrary.org/obo/NCIT_C39004) (B-Cell Survival Pathway))) 41.61%
- [NCIT:C36318](http://purl.obolibrary.org/obo/NCIT_C36318) (Microsatellite Instability) and (not ([NCIT:C38999](http://purl.obolibrary.org/obo/NCIT_C38999) (BARD1 Pathway))) 41.61%
- [NCIT:C36318](http://purl.obolibrary.org/obo/NCIT_C36318) (Microsatellite Instability) and (not ([NCIT:C38998](http://purl.obolibrary.org/obo/NCIT_C38998) (BAD Regulation Pathway))) 41.61%
- [NCIT:C36318](http://purl.obolibrary.org/obo/NCIT_C36318) (Microsatellite Instability) and (not ([NCIT:C38997](http://purl.obolibrary.org/obo/NCIT_C38997) (Cancer Susceptibility Pathway))) 41.61%
- [NCIT:C36318](http://purl.obolibrary.org/obo/NCIT_C36318) (Microsatellite Instability) and (not ([NCIT:C38996](http://purl.obolibrary.org/obo/NCIT_C38996) (ATM Signaling Pathway))) 41.61%
- [NCIT:C36318](http://purl.obolibrary.org/obo/NCIT_C36318) (Microsatellite Instability) and (not ([NCIT:C38995](http://purl.obolibrary.org/obo/NCIT_C38995) (Angiotensin II Signaling Pathway))) 41.61%
- [NCIT:C36318](http://purl.obolibrary.org/obo/NCIT_C36318) (Microsatellite Instability) and (not ([NCIT:C38992](http://purl.obolibrary.org/obo/NCIT_C38992) (Ribosomal Biogenesis Pathway))) 41.61%


